Wakelee HA - Search Results

1

Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With Radiation.

Thomas NJ, Myall NJ, Sun F, Patil T, Mushtaq R, Yu C, Sinha S, Pollom EL, Nagpal S, Camidge DR, Rusthoven CG, Braunstein SE, Wakelee HA, McCoach CE. Thomas NJ, et al. Among authors: wakelee ha. J Thorac Oncol. 2022 Jan;17(1):116-129. doi: 10.1016/j.jtho.2021.08.009. Epub 2021 Aug 26. J Thorac Oncol. 2022. PMID: 34455066 Free article.

2

Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.

Wakelee HA, Bernardo P, Johnson DH, Schiller JH. Wakelee HA, et al. Cancer. 2006 May 15;106(10):2208-17. doi: 10.1002/cncr.21869. Cancer. 2006. PMID: 16604529 Free article.

3

Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594.

Wakelee HA, Wang W, Schiller JH, Langer CJ, Sandler AB, Belani CP, Johnson DH; Eastern Cooperative Oncology Group. Wakelee HA, et al. J Thorac Oncol. 2006 Jun;1(5):441-6. J Thorac Oncol. 2006. PMID: 17409897 Free article. Clinical Trial.

4

Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors.

Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, Kee ST, Constantinescu D, Whyte RI, Donington J. Le QT, et al. J Thorac Oncol. 2006 Oct;1(8):802-9. J Thorac Oncol. 2006. PMID: 17409963 Free article. Clinical Trial.

5

Antibodies to vascular endothelial growth factor in non-small cell lung cancer.

Wakelee H. Wakelee H. J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S113-8. doi: 10.1097/JTO.0b013e318174e993. J Thorac Oncol. 2008. PMID: 18520292 Free article. Review.

6

Osteoblastic bone flare on F18-FDG PET in non-small cell lung cancer (NSCLC) patients receiving bevacizumab in addition to standard chemotherapy.

Krupitskaya Y, Eslamy HK, Nguyen DD, Kumar A, Wakelee HA. Krupitskaya Y, et al. Among authors: wakelee ha. J Thorac Oncol. 2009 Mar;4(3):429-31. doi: 10.1097/JTO.0b013e3181989e12. J Thorac Oncol. 2009. PMID: 19247091 Free article.

7

Vascular endothelial growth factor pathway.

Krupitskaya Y, Wakelee H. Krupitskaya Y, et al. J Thorac Oncol. 2009 Nov;4(11 Suppl 3):S1071-3. doi: 10.1097/01.JTO.0000361755.32660.a1. J Thorac Oncol. 2009. PMID: 19861922 Free article. No abstract available.

8

Antiangiogenic agents and vascular disrupting agents for the treatment of lung cancer: a review.

Clément-Duchêne C, Wakelee H. Clément-Duchêne C, et al. J Thorac Oncol. 2010 Jan;5(1):129-39. doi: 10.1097/JTO.0b013e3181c59a60. J Thorac Oncol. 2010. PMID: 19952799 Free article. Review.

9

Marked tumor response and fatal hemoptysis during radiation for lung cancer in a human immunodeficiency virus-positive patient taking nelfinavir.

Chapman CH, Shen J, Filion EJ, Tran PT, Hara W, Asuncion A, Marko D, Wakelee H, Berry GJ, Dimmick KW, Loo BW Jr, Green J. Chapman CH, et al. J Thorac Oncol. 2009 Dec;4(12):1587-9. doi: 10.1097/JTO.0b013e3181bf111d. J Thorac Oncol. 2009. PMID: 20009915 Free article. No abstract available.

10

A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer.

Clément-Duchêne C, Krupitskaya Y, Ganjoo K, Lavori P, McMillan A, Kumar A, Zhao G, Padda S, Zhou L, Pedro-Salcedo MS, Colevas AD, Wakelee HA. Clément-Duchêne C, et al. Among authors: wakelee ha. J Thorac Oncol. 2010 Nov;5(11):1821-5. doi: 10.1097/JTO.0b013e3181f1d23c. J Thorac Oncol. 2010. PMID: 20881641 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page